Skip to main content

Advertisement

Table 2 Characteristics of included abstracts from both periods

From: Reporting of critical care trial abstracts: a comparison before and after the announcement of CONSORT guideline for abstracts

  Pre-CONSORT Post-CONSORT p Value
Title 32.4 56.6 <0.001
Authors (for conference abstracts) N/A N/A
Trial design 22.7 16.3 0.130
Methods
 Participants 41.1 44.0 0.58
 Settinga 41.1 44.0 0.58
 Interventions 92.4 81.9 0.003
 Objective 93.5 95.2 0.50
 Outcome 31.4 49.4 0.001
 Randomization 1.1 1.8 0.57
 Blinding (masking) 3.2 4.2 0.63
Results
 Number randomized 41.6 37.4 0.41
 Recruitment 2.7 4.2 0.44
 Number analyzed 4.3 8.4 0.113
 Outcome 4.9 16.9 <0.001
 Effect sizea 4.9 20.5 <0.001
 Harms 11.9 27.7 <0.001
 Conclusion 97.3 97.0 0.86
 Trial registration 13.5 42.2 <0.001
 Funding 1.6 13.9 <0.001
  1. CONSORT Consolidated Standards of Reporting Trials, N/A not applicable
  2. Data are percentages representing the proportion of abstracts that adhered to the CONSORT guideline for abstracts
  3. aThese items were additionally examined in this study